Evidence map›Paper›PMID 37538979›Full record

ArticleRespiratory medicine case reports2023

A case of disseminated

Masashi Nishimura, Masao Okumura, Takii Takemasa, Takashi Yoshiyama, Yoshiaki Tanaka, Mikio Saotome, Ken Ohta

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Masashi NishimuraRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.
Masao OkumuraRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.
Takii TakemasaDepartment of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-tuberculosis Association, Japan.
Takashi YoshiyamaRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.
Yoshiaki TanakaRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.
Mikio SaotomeRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.
Ken OhtaRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.
Japan Anti Tuberculosis Association · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacillus Calmette-Guerin (BCG) intravesical injections are used as adjuvant therapy for superficial bladder cancer. We report a case of a 78-year-old man who developed disseminated

Indexed as

Bladder cancerMiliary tuberculosisMycobacterium bovis BCGMycobacterium tuberculosis intravesical BCG

Identifiers

PMID37538979
PMCPMC10393993
OpenAlexW4385076685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.